key: cord-0049094-g3ly269j
authors: Deshpande, Sanjay; Balaji, Sarath
title: MMR Vaccine and Covid-19: A Myth or a Low Risk-High Reward Preventive Measure?
date: 2020-07-24
journal: Indian Pediatr
DOI: 10.1007/s13312-020-1941-4
sha: 41854f4eae584b8c0ff1eabd3a30f9725f35dde2
doc_id: 49094
cord_uid: g3ly269j

nan

Published data highlights that immunity conferred by vaccination against Measles-Rubella (MR) vaccine persists for at least 20 years, and is generally thought to be lifelong for most individuals [1] . Emerging data speculates the role of live attenuated vaccines and the concept of 'trained innate immunity' offered by Bacillus Calmette Guerin (BCG) and MMR vaccine as an immune-prophylaxis against SARS-CoV 2 [1] . The molecular theory is based on overlapping of vaccine epitopes and amino acid residues between the Spike (S) glycoprotein of the SARS-CoV-2 virus with the Fusion (F1) glycoprotein of measles virus and the envelope (E1) glycoprotein of the rubella virus that possibly results in children presenting with a milder version of COVID-19 disease in contrast to adults [2] . As a result of these hypotheses, there has been an increase in adults opting to vaccinate themselves with the MMR vaccine.

We feel that this data may be more applicable to the Western population, particularly in the United States, and may not be applicable in India [3, 4] . Firstly, the Serum Institute of India Ltd manufactures the MMR vaccine used in India. This contains the Edmonston-Zagreb measles virus strain, which provides long-term sero-persistence of antibodies against measles in a majority of vaccinees as compared to other brands found across Western countries [3] . Secondly, a study of 192 college students in India found that the sero-prevalence of antibodies (IgG) to the three components of MMR vaccine was 91%, 97%, and 88%, respectively, even though 96% of the study population did not recollect their vaccination history [5] . Both of these studies suggest that antibodies to measles might well persist into adulthood and the need for an MMR vaccine to boost immunity may not be essential.

Okada, et al. [6] compared the analysis of host responses related to immunosuppression following natural measles infection and vaccination with a live attenuated measles vaccine and concluded that in contrast to wild-type measles virus (natural infection), live measles vaccines did not provoke the host cytokine response that leads to apoptotic cytolysis of uninfected lymphocytes, lymphopenia and immunosuppression, and thereby induced weaker immune responses to the virus. Published data from the United Kingdom (UK) revealed that macro domains of SARS-CoV-2 and rubella virus share 29% amino acid sequence identity, suggesting they have a similar protein fold. A cellular homolog of the methyltransferase from SARS coronavirus can be found in E.coli with

Measles immunization: Worth considering containment Strategy for SARS-CoV-2 global outbreak

Could an unrelated live attenuated vaccine serve as a preventive measure to dampen septic inflammation associated with COVID-19 Infection? mBio

Does early childhood vaccination protect against COVID-19?

Persistence of antibodies induced by measlesmumps-rubella vaccine in children in India

Seroprevalence of measles, mumps, and rubella antibodies in college students in Mumbai

Comparative analysis of host responses related to immunosuppression between measles patients and vaccine recipients with live attenuated measles vaccines

Sequence and structure analysis of distantly-related viruses reveals extensive gene transfer between viruses and hosts and among viruses